Character Bio

formerly Character Biosciences

Transforming Eye Care With Precision Medicine

Character Bio was founded in 2021, is headquartered in San Francisco, United States, lists 11–50 employees, and has $110.0M in recorded funding across 3 rounds.

Employees
11–50
Founded
2021
Business Model
B2B
Total Funding
$110.0M
Last Round
$17.0M Extension RoundSep 2025
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 7 investors for this company. The full record is or through the API.

About

Character Bio is a precision medicine company focused on progressive polygenic eye diseases, with an initial focus on age-related macular degeneration (AMD) and primary open-angle glaucoma. The company integrates proprietary genomic databases with longitudinal clinical data, imaging, and AI-enabled biomarker quantification to identify patient subtypes and genetic drivers of disease progression. This platform underpins a drug discovery and development pipeline targeting more precise, individualized therapies.

Summary

Character Bio is an Artificial Intelligence company based in San Francisco, United States, founded in 2021. It lists 11–50 employees. It has raised $110.0M in total across 3 rounds, most recently a $17.0M Extension Round in Sep 2025. Investors include aMoon, LUMA and Sanofi Ventures.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Extension RoundExtension RoundSep 2025
$17.0M

Sign up to see all 3 events

Funding: Series A through Extension Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Databricks

Databricks provides a unified data and AI platform that helps enterprises build and run applicati...

San Francisco, United States10001+Analytics, Artificial Intelligence
Series G+Total funding$20.0BJul 2026
PalantirIPO

Palantir Technologies builds data integration and analytics platforms (Gotham and Foundry) for go...

Denver, United States1001–5000Analytics, Artificial Intelligence
Private EquityTotal funding$3.1BJul 2020
Cyera

Cyera provides an AI-powered data security platform that helps security teams discover, control, ...

New York, United States201–500Artificial Intelligence, Cybersecurity
Extension RoundTotal funding$2.8BSep 2026
Isomorphic Labs

AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...

London, United Kingdom201–500Artificial Intelligence, Biotech
Series BTotal funding$2.6BMay 2026
Thinking Machine Labs

Thinking Machines Lab develops AI research and products that help people customize AI for their u...

San Francisco, United States11–50Artificial Intelligence, Data & Analytics
SeedTotal funding$2.0BJul 2025
Dataminr

Real-time AI platform that detects early signs of high-impact events and emerging risks from publ...

New York, United States501–1000Analytics, Artificial Intelligence
ConvertibleTotal funding$1.6BApr 2025

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Character Bio on Indexed.vc
<a href="https://indexed.vc/companies/character-bio"><img src="https://indexed.vc/api/badge/company/character-bio" alt="Character Bio on Indexed.vc" width="260" height="76" /></a>